Knowledge Distillery

Following the emergency use authorisation of the Pfizer–BioNTech mRNA COVID-19 vaccine BNT162b2 (international non-proprietary name tozinameran) in…

The consequences of COVID-19 in those who recover from acute infection requiring hospitalisation have yet to be clearly defined.

COVID-19 manifests with a wide spectrum of clinical phenotypes that are characterized by exaggerated and misdirected host immune responses.

Airborne transmission by droplets and aerosols is important for the spread of viruses. Face masks are a well-established preventive measure, but their…

SARS-CoV-2 vaccine rollout has coincided with the spread of variants of concern. In this article the authors investigated if single dose vaccination,…

The understanding of risk factors for COVID‑19, including pre-existing medical conditions and genetic variations, is limited. To what extent the…

Emerging data indicates an increased risk for cerebrovascular events with SARS-CoV-2 and highlights the potential impact of COVID-19 on the management…

The outbreak of the novel disease COVID-19 caused by the SARS-CoV-2 virus has rapidly spread around the world. Increasing evidence has suggested that…

The aim of this case-control study was to determine which characteristics and outcomes of stroke are associated with COVID-19. The study included…

In this paper, the authors evaluated incidence and clinical features of Guillain-Barre syndrome (GBS) in a cohort of patients from two regions of…

Since the COVID-19 pandemic, caused by SARS-CoV-2, a growing body of evidence indicates that, besides common COVID-19 symptoms, patients may develop…

The aim of the study was to assess the risk of hospitalisation for COVID‐19 and death in a cohort of patients with Parkinson’s disease or Parkinsonism…